The most frequently reported side effects included infusion reactions, neutropenia, thrombocytopenia, anemia, pyrexia, cough, and musculoskeletal disorders.
Frequency not reported: Worsening of preexisting cardiac conditions with fatalities, atrial fibrillation
Very common (10% or more): Neutropenia (40%), thrombocytopenia (15%), anemia (12%)Common (1% to 10%): Leukopenia (7%)
Very common (10% or more): AST (SGOT) increased (28%), ALT (SGPT) increased (25%)
Very common (10% or more): Hypocalcemia (32%), hyperkalemia (31%), hyponatremia (29%), hypoalbuminemia (22%), alkaline phosphatase increased (16%), hypokalemia (13%)Common (1% to 10%): Grade 3 or 4 tumor lysis syndrome (2%)
Very common (10% or more): Musculoskeletal disorders including pain (17%)
Frequency not reported: Progressive multifocal leukoencephalopathy
Very common (10% or more): Infusion related reactions (69%), pyrexia (10%)
Very common (10% or more): Creatinine increased (30%)
Very common (10% or more): Cough (10%)
Very common (10% or more): Positive test for anti-obinutuzumab (the active ingredient contained in Gazyva) antibodies (13%)Common (1% to 10%): Infection (9%)Frequency not reported: Hepatitis B reactivation
Back pain
black, tarry stools
bleeding gums
blood in the urine or stools
chest tightness
chills
cough or hoarseness
fever
flushing
headache
lower back or side pain
nausea and vomiting
painful or difficult urination
pale skin
pinpoint red spots on the skin
sore throat
trouble breathing
troubled breathing with exertion
ulcers, sores, or white spots in the mouth
unusual bleeding or bruising
unusual tiredness or weakness
Joint pain, stiffness, or swelling
lower back, side, or stomach pain
swelling of the feet or lower legs
Blurred vision
confusion
convulsions
dark urine
dizziness
drowsiness
general tiredness and weakness
headache
light-colored stools
upper right abdominal or stomach pain
yellow eyes and skin
Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site